SCHEMBL18464809

SCHEMBL18464809

Cc1ccc2cc(-c3ccc(-c4ccc5cc(C)ccc5c4)c4nsnc34)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.46
▸ CYP2A6 P11509 3/20 0.46
▸ TDP1 Q9NUW8 1/20 0.41
▸ ESR1 P03372 4/20 0.40
▸ ESR2 Q92731 4/20 0.40
▸ CCR1 P32246 1/20 0.38
▸ CCR5 P51681 1/20 0.38
▸ CCR8 P51685 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NCK1 P16333 1/20 0.34
▸ BACE1 P56817 1/20 0.34
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22338535 0.94 CYP2A6 (0.53) CYP1A2CYP2A6TDP1ESR1ESR2
SCHEMBL18464129 0.84 CYP2A6 (0.38) CYP1A2CYP2A6TDP1ESR1ESR2
SCHEMBL24270298 0.81 GSTP1 (0.52) CYP1A2ESR1ESR2ALDH1A1CYP2C9
SCHEMBL862821 0.81 COMT (0.40) TDP1ALDH1A1TSHRSMN1; SMN2MEN1
SCHEMBL711834 0.79 GSTP1 (0.57) CYP1A2CYP2A6CYP3A4CYP2C9CYP11B1
SCHEMBL20806202 0.79 COMT (0.39) TDP1ALDH1A1TSHRSMN1; SMN2MEN1
SCHEMBL24270301 0.78 RAB9A (0.46) ALDH1A1HPGDTSHRSMN1; SMN2ABL1
SCHEMBL21537531 0.78 PDE3B (0.34) CYP1A2CYP2A6ESR1ESR2ALDH1A1
SCHEMBL20647415 0.77 PDE3B (0.39) BACE1MEN1NPC1RAB9AKMT2A
SCHEMBL21935453 0.75 PDE3B (0.38) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230053362-A1 DICHROIC DYE COMPOSITION MERCK PATENT GMBH (DE) 2023-02-23 — — US disclosed
WO-2020158211-A1 LIQUID CRYSTAL COMPOSITE BODY, LIQUID CRYSTAL LIGHT CONTROL ELEMENT AND LIGHT CONTROL WINDOW JNC株式会社 2020-08-06 — — WO disclosed
US-10723950-B2 Liquid-crystalline mixtures MERCK PATENT GMBH (DE) 2020-07-28 — — US disclosed
EP-3458549-B1 LIQUID-CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
EP-3400271-B1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
EP-3400270-B1 DEVICE FOR REGULATING ENTRY OF LIGHT MERCK PATENT GMBH (DE) 2020-04-29 — — EP disclosed
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound MERCK PATENT GMBH (DE) 2019-07-09 — — US disclosed
US-10260001-B2 Liquid crystal material MERCK PATENT GMBH (DE) 2019-04-16 — — US disclosed
US-20190016955-A1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2019-01-17 — — US disclosed
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound CRY1, SLC25A1, CRY2 CYP1A2 2025/4885CYP2A6 4037/4885TDP1 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback